Letters in Drug Design & Discovery
Brief Name:
LETT DRUG DES DISCOV
Impact factor:
1.2 (2023)
ISSN:
1570-1808
Open Access:
No
Publisher:
Bentham Science Publishers B.V.
Publication Frequency:
Bimonthly
Publication Start Year:
2004
Annual Articles:
183
Self-citation Rate:
8.3%
Chinese Academy of Sciences SCI Journal Classification:
| Major category | Ｍinor category | TOP journal | Ｒeview journal |
|---|---|---|---|
Q4 MEDICAL |
MEDICINAL CHEMISTRY | No | No |
Subject Classification:
CHEMISTRY, MEDICINAL
CiteScore:
| CiteScore | SJR | SNIP | CiteScore ranking | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1.8 | 0.222 | 0.364 |
|
H-Index:
28
SCI Index Status:
Science Citation Index Expanded
PubMed Central:
Submission Site:
Aims and Scope:
Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.
Disclaimer:
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.
This page displays information about journals or magazines for reference and study purposes only. It is not the official website of any journal or magazine and does not involve publishing matters. Users must verify any publishing-related inquiries directly with the publisher.
If there are any issues with the content displayed on this page, please contact us at: [email protected], and we will verify and address the matter diligently.